@article{5563b53ef95a4435bdb971ed471243b3,
title = "Anaplastic thyroid carcinoma, version 2.2015",
abstract = "This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Thyroid Carcinoma focuses on anaplastic carcinoma because substantial changes were made to the systemic therapy recommendations for the 2015 update. Dosages and frequency of administration are now provided, docetaxel/doxorubicin regimens were added, and single-agent cisplatin was deleted because it is not recommended for patients with advanced or metastatic anaplastic thyroid cancer.",
author = "Haddad, {Robert I.} and Lydiatt, {William M.} and Ball, {Douglas W.} and Busaidy, {Naifa Lamki} and David Byrd and Glenda Callender and Paxton Dickson and Duh, {Quan Yang} and Hormoz Ehya and Megan Haymart and Carl Hoh and Hunt, {Jason P.} and Andrei Iagaru and Fouad Kandeel and Peter Kopp and Lamonica, {Dominick M.} and McCaffrey, {Judith C.} and Moley, {Jeffrey F.} and Lee Parks and Raeburn, {Christopher D.} and Ridge, {John A.} and Ringel, {Matthew D.} and Scheri, {Randall P.} and Shah, {Jatin P.} and Smallridge, {Robert C.} and Cord Sturgeon and Wang, {Thomas N.} and Wirth, {Lori J.} and Hoffmann, {Karin G.} and Miranda Hughes",
note = "Publisher Copyright: {\textcopyright} JNCCN-Journal of the National Comprehensive Cancer Network.",
year = "2015",
month = sep,
day = "1",
doi = "10.6004/jnccn.2015.0139",
language = "English (US)",
volume = "13",
pages = "1140--1150",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "9",
}